| |
| |
|
| Insider
Information: |
Bhonsle Sunil |
| Relationship: |
See Remarks, Director |
| City: |
So. San Francisco, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
435,578 |
|
|
Indirect Shares
|
54,684 |
|
|
| Direct
Value |
$191,654 |
|
|
|
Indirect Value
|
$24,061 |
|
|
| Total
Shares |
490,262 |
|
|
| Total
Value |
$215,715 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Titan Pharmaceuticals Inc |
TTNP |
See Remarks, Director |
2018-09-21 |
435,578 |
2018-09-21 |
54,684 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TTNP |
Titan Pharmaceuticals Inc |
See Remarks |
• • – |
2018-09-21 |
4 |
B |
$0.25 |
$75,000 |
D/D |
300,000 |
435,578 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President and CEO |
• • – |
2016-07-18 |
4 |
B |
$4.96 |
$49,550 |
D/D |
10,000 |
135,578 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President and CEO |
• • – |
2016-02-22 |
4 |
B |
$3.56 |
$41,817 |
D/D |
11,763 |
125,578 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President and CEO |
• • – |
2016-01-15 |
4 |
B |
$2.72 |
$15,888 |
D/D |
5,841 |
113,815 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President and CEO |
• • – |
2016-01-11 |
4 |
B |
$3.18 |
$54,060 |
D/D |
17,000 |
107,974 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2015-10-01 |
4 |
B |
$3.99 |
$798 |
D/D |
200 |
90,974 |
2.73 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2015-09-30 |
4 |
B |
$3.98 |
$1,990 |
D/D |
500 |
90,774 |
2.73 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2015-09-28 |
4 |
B |
$3.62 |
$3,296 |
D/D |
910 |
90,274 |
2.73 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2015-09-16 |
4 |
B |
$0.70 |
$3,500 |
D/D |
5,000 |
491,500 |
2.73 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2015-09-15 |
4 |
B |
$0.69 |
$3,450 |
D/D |
5,000 |
486,500 |
2.73 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2015-08-25 |
4 |
B |
$0.70 |
$34,800 |
D/D |
50,000 |
481,500 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2014-10-13 |
4 |
B |
$0.47 |
$43,240 |
D/D |
92,000 |
356,500 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2014-10-10 |
4 |
B |
$0.49 |
$11,688 |
D/D |
24,000 |
0 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2014-10-09 |
4 |
B |
$0.48 |
$47,800 |
D/D |
100,000 |
0 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2014-02-12 |
4 |
A |
$0.66 |
$66,000 |
D/D |
100,000 |
215,500 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2013-06-18 |
4 |
B |
$0.46 |
$22,770 |
D/D |
50,000 |
115,500 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2013-02-25 |
4 |
OE |
$1.50 |
$75,000 |
D/D |
50,000 |
65,500 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
President |
• • – |
2011-11-18 |
4 |
B |
$1.32 |
$32,900 |
D/D |
25,000 |
65,500 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
PresidentOfficer |
• • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
225,757 |
|
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
PresidentOfficer |
• • – |
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
65,500 |
|
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive VP and COO |
• • – |
2008-10-21 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
365,500 |
0 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive VP and COO |
• • – |
2008-02-11 |
4 |
B |
$1.25 |
$25,000 |
I/I |
20,000 |
95,894 |
2.66 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive VP and COO |
• • – |
2007-05-22 |
4 |
B |
$2.02 |
$30,300 |
I/I |
15,000 |
75,894 |
2.66 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
Executive VP and COO |
• • – |
2007-05-17 |
4 |
B |
$2.00 |
$12,250 |
D/D |
6,100 |
65,500 |
2.81 |
- |
|
| TTNP |
Titan Pharmaceuticals Inc |
EVP and COO |
• • – |
2005-11-07 |
4 |
B |
$1.40 |
$43,000 |
D/D |
30,000 |
59,400 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
